Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II studyRobert I. Haddad, Marshall R. Posner, A. Dimitrios Colevas et al.|Oral Oncology|2003Cited by 262
Clinical and Serologic Responses After a Two-dose Series of High-dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-arm TrialAndrew R. Branagan, Madhav V. Dhodapkar, Daniel Zelterman et al.|Clinical Lymphoma Myeloma & Leukemia|2017Cited by 48
Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasiasAndrew R. Branagan, Madhav V. Dhodapkar, Eamon Duffy et al.|Blood Advances|2021Cited by 21
Fluzone® High-Dose Influenza Vaccine with a Booster Is Associated with Low Rates of Influenza Infection in Patients with Plasma Cell DisordersAndrew R. Branagan, Madhav V. Dhodapkar, Eamon Duffy et al.|Blood|2015Cited by 1